Journal Watch · Nature Communications · 2026

Woven dECM yarn scaffolds enable volumetric muscle loss regeneration via immunomodulation.

Our study shows that restructured dECM scaffolds address structural constraints to enable effective in situ muscle regeneration, while simultaneously establishing a novel scaffold platform for regenerative medicine.

Song G, Cong W, Lu H et al.Nature Communications3 min readPharma relevance 50/100

DOI: 10.1038/s41467-026-77032-yPMID: 42805971Study type: preclinical (animal / model) study

TL;DR

Our study shows that restructured dECM scaffolds address structural constraints to enable effective in situ muscle regeneration, while simultaneously establishing a novel scaffold platform for regenerative medicine.

Key findings

  • The robust regenerative efficacy and translational potential of YS was further confirmed in a canine VML model.
  • Our study shows that restructured dECM scaffolds address structural constraints to enable effective in situ muscle regeneration, while simultaneously establishing a novel scaffold platform for regenerative medicine.

What they did

Here, we report a dECM yarn scaffold (YS) fabricated by 3D weaving of rotary-cut yarns, achieving precise structural control, full interconnectivity and high porosity. In murine VML models, YS significantly improved vascularization, innervation, muscle mass, and strength restoration. Single-nucleus RNA-sequencing identified decreased SPP1<sup>+</sup> neutrophil infiltration alongside increased CD206<sup>+</sup>/IGF-1<sup>+</sup> macrophages, whose enhanced IGF-1 secretion stimulated PAX7<sup>+</sup> muscle cell growth via amplified IGF-1R signaling.

Full abstract (original)

Background: Volumetric muscle loss (VML) represents a significant unmet clinical need in current medical practice. Decellularized extracellular matrix (dECM) offers a promising clinical approach. However, its inherent architecture impedes adaptive topological guidance for rapid cellular infiltration, spatial organization, and coordinated immune response, limiting functional restoration.

What they did: Here, we report a dECM yarn scaffold (YS) fabricated by 3D weaving of rotary-cut yarns, achieving precise structural control, full interconnectivity and high porosity. In murine VML models, YS significantly improved vascularization, innervation, muscle mass, and strength restoration. Single-nucleus RNA-sequencing identified decreased SPP1<sup>+</sup> neutrophil infiltration alongside increased CD206<sup>+</sup>/IGF-1<sup>+</sup> macrophages, whose enhanced IGF-1 secretion stimulated PAX7<sup>+</sup> muscle cell growth via amplified IGF-1R signaling.

Results & conclusions: The robust regenerative efficacy and translational potential of YS was further confirmed in a canine VML model. Our study shows that restructured dECM scaffolds address structural constraints to enable effective in situ muscle regeneration, while simultaneously establishing a novel scaffold platform for regenerative medicine.

Abstract © the authors / Nature Communications (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1038/s41467-026-77032-y · PubMed 42805971.

Why it matters for pharma & biotech

  • Relevant to General & Medicine teams tracking Nature Communications for new targets, mechanisms and biomarkers.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The work is preclinical. Results in animal or cell models frequently do not translate directly to human efficacy or safety.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Nature Communications study find?

Our study shows that restructured dECM scaffolds address structural constraints to enable effective in situ muscle regeneration, while simultaneously establishing a novel scaffold platform for regenerative medicine.

What type of study is this?

It is a preclinical (animal / model) study, published in Nature Communications in 2026. Here, we report a dECM yarn scaffold (YS) fabricated by 3D weaving of rotary-cut yarns, achieving precise structural control, full interconnectivity and high porosity.

Where can I read the original paper?

The original is at the publisher via DOI 10.1038/s41467-026-77032-y. PubMed ID: 42805971. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Song G, Cong W, Lu H et al.. Woven dECM yarn scaffolds enable volumetric muscle loss regeneration via immunomodulation.. Nature Communications (2026). DOI: 10.1038/s41467-026-77032-y.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/woven-decm-yarn-scaffolds-enable-volumetric-muscle-loss-regeneration-via-77032y/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides